Banque Pictet & Cie SA lifted its holdings in shares of Aetna Inc. (NYSE:AET) by 1.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 70,310 shares of the company’s stock after buying an additional 714 shares during the quarter. Banque Pictet & Cie SA’s holdings in Aetna were worth $11,180,000 at the end of the most recent quarter.
Other large investors have also modified their holdings of the company. Capital World Investors grew its holdings in Aetna by 8.9% during the second quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock valued at $3,153,358,000 after purchasing an additional 1,688,767 shares during the period. FMR LLC grew its holdings in Aetna by 73.8% during the second quarter. FMR LLC now owns 13,736,800 shares of the company’s stock valued at $2,085,659,000 after purchasing an additional 5,833,567 shares during the period. Janus Henderson Group PLC grew its holdings in Aetna by 9,446.2% during the second quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock valued at $657,255,000 after purchasing an additional 4,283,553 shares during the period. UBS Asset Management Americas Inc. grew its holdings in Aetna by 7.5% during the second quarter. UBS Asset Management Americas Inc. now owns 2,553,496 shares of the company’s stock valued at $387,697,000 after purchasing an additional 177,364 shares during the period. Finally, LSV Asset Management grew its holdings in Aetna by 8.7% during the second quarter. LSV Asset Management now owns 2,467,782 shares of the company’s stock valued at $374,683,000 after purchasing an additional 198,214 shares during the period. Institutional investors own 90.93% of the company’s stock.
Aetna Inc. (AET) traded up $3.76 during midday trading on Friday, reaching $174.76. 2,175,200 shares of the company’s stock traded hands, compared to its average volume of 2,437,205. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.53 and a quick ratio of 0.53. Aetna Inc. has a 1 year low of $116.04 and a 1 year high of $184.98. The company has a market capitalization of $56,920.00, a price-to-earnings ratio of 16.75, a P/E/G ratio of 1.56 and a beta of 0.61.
Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.06 by $0.39. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The firm had revenue of $14.99 billion for the quarter, compared to analyst estimates of $15.12 billion. During the same period in the prior year, the firm posted $2.07 earnings per share. The company’s quarterly revenue was down 5.0% compared to the same quarter last year. sell-side analysts expect that Aetna Inc. will post 9.78 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Thursday, October 12th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.14%. The ex-dividend date of this dividend was Wednesday, October 11th. Aetna’s dividend payout ratio (DPR) is currently 36.97%.
A number of research analysts recently issued reports on AET shares. BMO Capital Markets boosted their price objective on shares of Aetna from $175.00 to $200.00 and gave the company a “market perform” rating in a report on Friday, October 27th. Argus reiterated a “buy” rating and issued a $185.00 price target (up previously from $165.00) on shares of Aetna in a report on Tuesday, September 12th. Zacks Investment Research upgraded shares of Aetna from a “hold” rating to a “strong-buy” rating and set a $184.00 price target for the company in a report on Wednesday, October 25th. Cantor Fitzgerald cut shares of Aetna from an “overweight” rating to a “neutral” rating in a report on Thursday, October 26th. Finally, Morgan Stanley upped their price target on shares of Aetna from $172.00 to $179.00 and gave the company an “overweight” rating in a report on Thursday, August 17th. Eleven analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Aetna currently has a consensus rating of “Buy” and an average target price of $172.36.
In other news, EVP Margaret M. Mccarthy sold 10,288 shares of the stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $162.85, for a total value of $1,675,400.80. Following the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at $5,465,734.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Karen S. Lynch sold 15,271 shares of the stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the transaction, the president now directly owns 64,261 shares in the company, valued at $10,404,498.51. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.